Europe's high-tech issuers are spoilt for choice
Something is stirring in the world of small cap, high-tech Euro-stocks. Could it be that at last continental European investors are developing a taste for the riskier end of equity market investment? That the long-held hope of a true equity culture in those bastions of fixed-income investment is finally in evidence? To the extent that there is now a liquid market for start-up biotech stocks, the riskiest of all companies?
It's a world in which anything might happen next but, for now at least,
You need to register to access 3 free deep dive articles per month. To continue reading please register or login below..
- Unlimited deep dives
- Data-driven research around key topics
- Buy-side insights
- Benchmarking reports
From
$1495
Janet Dignan
Janet Dignan is a graduate of Otago University in New Zealand, where she read philosophy. From 1979 to1982 she was head of information at Linklaters, with responsibility for internal and external information resources for its offices in London, Hong...
Founding editor
